PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-76.02%
Negative net income growth while MRVL stands at 97.45%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.83%
D&A growth well above MRVL's 1.73%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
100.00%
Deferred tax of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-100.00%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-448.87%
Negative yoy working capital usage while MRVL is 61.66%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-5668.64%
Negative yoy inventory while MRVL is 167.21%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Negative yoy AP while MRVL is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-617.84%
Both reduce yoy usage, with MRVL at -2137.87%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
682.30%
Growth of 682.30% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
-146.99%
Negative yoy CFO while MRVL is 89.79%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
10.60%
CapEx growth well above MRVL's 6.96%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
86.34%
Purchases well above MRVL's 56.81%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-38.13%
Both yoy lines are negative, with MRVL at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
110.26%
We have mild expansions while MRVL is negative at -32.65%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-69.66%
Negative yoy issuance while MRVL is 70.21%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.